Navigation Links
Synthetic Biologics Reports Third Quarter 2012 Financial Results

filings with the SEC. The information in this release is provided only as of the date of this release, and Synthetic Biologics undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

 Synthetic Biologics, Inc. and Subsidiaries(in thousands, except share data)Condensed Consolidated Balance SheetsSeptember 30,December 31,20122011(Unaudited)(Audited)AssetsCash

,678Accounts receivable, net


15116Assets of discontinued operations

-23Property and equipment, net

249323Long-term note receivable

700-Deposits and other assets

2731Total assets

7,476Liabilities and Stockholders' EquityCurrent liabilities

417Stockholders' equity

5,4097,059Total liabilities and stockholders' equity

7,476 Condensed Consolidated Statements of Operations (Unaudited)For the three months ended
September 30,For the nine months ended
September 30,2012201120122011Operating Costs and ExpensesGeneral and administrative

2,339Research and development

7632891,696801Total operating costs and expenses

1,8368715,4133,140Loss from Continuing Operations(1,836)(871)(5,413)(3,140)Other Income (Expense)Warrant expense  

---(1,492)Change in fair value of warrant liability

-(165)-(242)Other income (expense)

1062255Total other income (expense), net

10(159)22(1,679)Loss from Continuing Operations(1,826)(1,030)(5,391)(4,819)Income (Loss) from Discontinued Operations(104)(68)389(145)Net Loss and Comprehensive Loss$
(4,964)Net Income (Loss) Per Share - Basic and DilutiveContinuing Operations

(0.18)Discontinued Oper

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Synthetic Biologics to Acquire Clinical-Stage C. difficile Infectious Disease Program
2. Taming mavericks: Stanford researchers use synthetic magnetism to control light
3. Synthetic Biologics Completes $10.8 Million Private Placement Financing
4. Synthetic Biologics Announces $10.8 Million Financing
5. Synthetic Genomics Inc. Purchases Patent Portfolio from Febit Holding GmbH
6. Synthetic Biology Market is Expected to Reach USD 16.7 Billion Globally in 2018: Transparency Market Research
7. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
8. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
9. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
10. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
11. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimestaâ„¢ for Multiple Sclerosis
Post Your Comments:
(Date:8/1/2014)... Applied DNA Sciences, Inc. (OTCQB: ... and product authentication solutions, will host a conference call ... third quarter results. The Quarterly Report on Form 10Q ... of the day on Monday August 11, 2014. ... conference call beginning at 9:00 A.M. Eastern Daylight Time ...
(Date:8/1/2014)... , Aug. 1, 2014 Research ... "The World Market for Flow Cytometry in ... ... are now an important component of advanced IVD ... instruments for cancer diagnostics, but their newer clinical ...
(Date:8/1/2014)... , Aug. 1. 2014 As one of ... 2014 AACC Annual Meeting & Clinical Lab Expo is ... patient care are introduced to the healthcare world. This ... Expo,s 650 exhibitors will include the latest diagnostic technology ... Advances in smartphones and biosensors have enabled the development ...
(Date:8/1/2014)... -- One of the major revolutions taking place in ... the practice of using genomic and other molecular analyses ... Personalized diagnostics—laboratory analyses that inform the practice of personalized ... This fall, AACC ,s first ever virtual ... exciting field and the novel technologies driving it forward, ...
Breaking Biology Technology:Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 2Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 3The World Market for Flow Cytometry in IVD Applications 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 3First-Ever AACC Virtual Conference to Focus on Personalized Diagnostics 2
... review activities, TSX Exchange Symbol: RVX, ... Resverlogix,Corp. ("Resverlogix" or the "Company") (TSX:RVX) the Board ... discussions with third parties,feel it is prudent to ... announced strategic review process of January 25, 2007. ...
... Exchange Symbol: MS, EDMONTON, Sept. 3 /PRNewswire-FirstCall/ ... in the treatment of multiple sclerosis (MS), announced,today ... bid. Under the bid,which will be conducted pursuant ... the Company may purchase up to 1,000,000 of ...
... China, Sept. 3 ,Acesys Pharmatech and Provid Pharmaceuticals ... expertise and project management,capabilities of Provid in the ... structure of Acesys in China., The combined ... of medicinal chemistry for clients in the pharmaceutical ...
Cached Biology Technology:Resverlogix Board of Directors Update 2BioMS Medical announces its intention to renew a normal course issuer bid 2BioMS Medical announces its intention to renew a normal course issuer bid 3Acesys and Provid Announce Alliance for Medicinal Chemistry Services 2
(Date:8/1/2014)... of the most diverse families in the ocean today ... -- originated more than 400 million years ago in ... those of its modern members. This Geology ... published online on 25 July 2014, tracks the remarkable ... , At is origin, the Lucinidae family remained at ...
(Date:8/1/2014)... a more effective way to control the condition, thanks ... National University of Singapore (NUS). , The team, led ... Pharmacology at the NUS Yong Loo Lin School of ... PhD graduate from the Saw Swee Hock School of ... herbal-based anti-malarial drug, can be used to control asthma, ...
(Date:8/1/2014)... two Simon Fraser University research associates, cite new ... collaborate closely on minimizing damage to the natural ... Maureen Ryan, David H. Smith Conservation Research Fellows ... international co-authors of the newly published research in ... , Shale gas development is the extraction of ...
Breaking Biology News(10 mins):Symbiotic survival 2Symbiotic survival 3Symbiotic survival 4Symbiotic survival 5Symbiotic survival 6Symbiotic survival 7Symbiotic survival 8Symbiotic survival 9Symbiotic survival 10Symbiotic survival 11Symbiotic survival 12Symbiotic survival 13Symbiotic survival 14NUS study shows effectiveness of common anti-malarial drug in controlling asthma 2Scientists warn time to stop drilling in the dark 2Scientists warn time to stop drilling in the dark 3
... the skeletal support for the membrane in animal cells ... the Physico Chemistry Curie Unit at the Curie Institute ... layer beneath the cell outer membrane forms beyond a ... within the cellular system. These findings, which offer a ...
... In India most people who are HIV positive don,t ... available. It would therefore meet international standards of cost-effectiveness ... every person in the billion-plus population every five years according ... One . The findings are based on a careful ...
... 2013 at the Best Western Ramkota Rapid City Hotel & ... Society of America,s North Central Branch holds its 68th Annual ... Forests pests, such as the mountain pine beetle and the ... the western corn rootworm, the soybean aphid, and the twospotted ...
Cached Biology News:Cost-effective: Universal HIV testing in India 2Cost-effective: Universal HIV testing in India 3Cost-effective: Universal HIV testing in India 4
Reacts with methylated DNA from plants and vertebrates...
Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Biology Products: